Metropolis Healthcare, India’s second-largest pathology laboratory chain, has inaugurated a state-of-the-art diagnostic laboratory in Dibrugarh, Assam. The facility, spanning approximately 1,200 sq. ft., is equipped to process up to 15,000 samples monthly and offers a wide range of tests, from routine pathology to specialized diagnostics. The inauguration ceremony was attended by Dr. Aprajit Sandilya, Director of Urovision Hospital, alongside Metropolis Healthcare senior officials, including Mr. Rajesh Tripathy and Mr. Anindya Majumdar. The lab marks Metropolis’ fifth processing facility in Assam, further strengthening healthcare access in the region.
Mr. Bhoopendra Singh Rajawat, Chief Business Officer (West, East & North India), Metropolis Healthcare Limited said: “The launch of this diagnostic laboratory in Dibrugarh reaffirms our commitment to delivering advanced, high-quality diagnostics closer to communities in Tier 2 and Tier 3 towns. By leveraging cutting-edge technology and the expertise of our skilled professionals, we aim to strengthen the local healthcare ecosystem with fast, accurate, and reliable diagnostic services. We look forward to working closely with local hospitals, specialists, general physicians, and the government to ensure better healthcare outcomes for patients.”
Dr. Ronica Baruah, Director and Chief of Lab Services, Ekopath Metropolis Lab Services Private Limited commented: “We are excited to bring our expertise in accurate diagnostics and super-specialty pathology services to doctors and patients in Dibrugarh city. Whether for wellness, chronic disease management, or complex areas like oncology and transplant immunology, we are committed to setting new benchmarks in precise diagnosis and patient-focused care. Our dedication to assisting patients at every stage of disease detection remains unwavering.” The launch is expected to benefit Dibrugarh, which serves as a healthcare hub for Upper Assam and neighboring states. The new facility is set to improve early disease detection and chronic disease management, catering to the growing demand for quality diagnostics in the region.